• Citer

A randomized controlled phase ii trial of a novel composition of paclitaxel embedded into neutral and cationic lipids targeting tumor endothelial cells in advanced triple-negative breast cancer (tnbc)

par Awada, Ahmad ;Piccart-Gebhart, Martine ;Bondarenko, Igor I.N.;Bonneterre, Jacques;Nowara, Elzbieta;Ferrero, Jean Marc;Bakshi, Ashish Vijay;Wilke, Cailin Moira C.
Référence Annals of oncology, 25, 4, page (824-831), mdu025
Publication Publié, 2014

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	A randomized controlled phase ii trial of a novel composition of paclitaxel embedded into neutral and cationic lipids targeting tumor endothelial cells in advanced triple-negative breast cancer (tnbc)
Auteur:	Awada, Ahmad; Piccart-Gebhart, Martine; Bondarenko, Igor I.N.; Bonneterre, Jacques; Nowara, Elzbieta; Ferrero, Jean Marc; Bakshi, Ashish Vijay; Wilke, Cailin Moira C.
Informations sur la publication:	Annals of oncology, 25, 4, page (824-831), mdu025
Statut de publication:	Publié, 2014
Sujet CREF:	Hématologie
	Cancérologie
Mots-clés:	Activated tumor endothelial cells
	Advanced disease
	Cationic liposomes of paclitaxel
	EndoTAG-1
	Lipid-embedded paclitaxel
	Triple-negative breast cancer
MeSH keywords:	Adult
	Aged
	Combined Modality Therapy
	Disease-Free Survival
	Drug-Related Side Effects and Adverse Reactions -- classification -- pathology
	Endothelial Cells -- drug effects
	Female
	Humans
	Lipids -- administration & dosage -- chemistry
	Middle Aged
	Paclitaxel -- administration & dosage -- chemistry
	Triple Negative Breast Neoplasms -- drug therapy -- pathology
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0923-7534
	info:doi/10.1093/annonc/mdu025
	info:pii/mdu025
	info:scp/84897087162
	info:pmid/24667715